Targeted Next Generation Sequencing for the Efficacy of Trastuzumab Neoadjuvant Chemotherapy in Breast Cancer
Status: UNKNOWN
Study type: OBSERVATIONAL
Conditions: Observational|Prospective
Interventions: DRUG: Trastuzumab+TP
Sponsor: Hebei Medical University Fourth Hospital
Collaborators: OrigiMed